CClinicalTrials.gg
CompletedNCT01244022Updated Jul 16, 2013

Cytokine Changes After Colorectal Cancer Resection

An observational study in Colorectal Cancer, sponsored by University Hospital Dubrava. Completed at 1 site in Croatia. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2013-07-16.

Sponsored by University Hospital Dubrava · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
28
Ages
20 Years to 90 Years
Sex
All
01

Study summary

Based on our previous research, this study aims to determine reliable surgical stress response markers in patients undergoing radical resection of colorectal cancer.

Read the detailed description

Every surgical intervention represents a stress for patient's organism. During the operation, numerous changes in the patient's metabolism take place, that are termed surgical stress response. Leading cause of surgical stress response is tissue destruction that always accompanies operations. Surgical stress response is effected through activation of hypothalamus-pituitary-adrenal axis and through sympathetic activation.

The consequences of surgical stress response are numerous. Surgical stress response is essential to uneventful postoperative recovery. On the other hand, excessive surgical stress response may lead to serious postoperative complications, such as heart and kidney failure, venous thrombosis, disruption of operative wound and wound infection.

In prior studies the investigators have shown the kinetics of postoperative serum interleukin changes after radical resection of gastric cancer.

This study aims at determining reliable markers of surgical stress response severity in patients undergoing radical resection of colorectal cancer.

02

Conditions studied

  • Colorectal Cancer

Keywords

  • Colorectal cancer
  • Surgical stress response
  • interleukins
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's enrollment of 28 is below the median of 250 across 1,226 observational studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

University Hospital Dubrava is the lead sponsor of 39 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with colorectal cancer treated in the University Hospital Dubrava

Inclusion criteria

  • Pathohistologically verified colorectal cancer

Exclusion criteria

Exclusion Criteria:

  • Distant metastases noticed before or during surgery
  • History of autoimmune diseases or immunodeficiencies
  • Use of immunomodulatory drugs within 1 year prior to surgery
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
28 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Colorectal cancer patients

    Patients with pathohistologically verified colorectal cancer or adenoma with epithelial dysplasia

    Procedure: colorectal cancer resection

Interventions

  • Procedurecolorectal cancer resection

    Open radical resection of colorectal cancer, according to oncological principals, depending on the tumor site

    Also known as: Hemicolectomy, Rectosigmoid resection

06

What researchers measure

Primary outcomes

  1. Postoperative changes of serum cytokine levels

    Serum cytokine levels will be determined at 1st, 2nd and 7th postoperative day and compared to preoperative values.

    Time frame: 1 day, 2 days and 7 days postoperatively

Secondary outcomes

  1. Early postoperative complications

    Time frame: Within one month after surgery

07

Study locations

1 site
  • University Hospital Dubrava
    Zagreb, 10000, Croatia
08

References and documents

Publications

  • Servis D, Busic Z, Stipancic I, Patrlj L, Gagro A. Serum cytokine changes after gastric resection or gastrectomy for gastric cancer. Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1868-72. PubMed 19102411 ↗
  • Etherek L, Servis D, Unic A. Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Inflammatory Markers in Colorectal Cancer Surgery: A Prospective Cohort Study. Chin Med J (Engl). 2017 Nov 20;130(22):2691-2696. doi: 10.4103/0366-6999.218022. PubMed 29133757 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 16, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01244022
Lead sponsor
University Hospital Dubrava
Responsible party
Drazen Servis (M.D., Ph. D., University Hospital Dubrava) — Principal investigator
First posted
Nov 19, 2010
Start date
Aug 2010
Primary completion
Dec 2012
Completion
Dec 2012
Last update
Jul 16, 2013

Study contacts

Drazen Servis, M.D., Ph.D.
principal investigator · University Hospital Dubrava

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion